Recommendation of the CAVEI on the incorporation of tetravalent vaccine conjugated against meningococo in infants and adolescents

CAVEI recommends the incorporation of conjugated meningococcal vaccine with coverage for serotype W from two months of age in a dose scheme of 2 + 1 to achieve the group's direct protection to the most vulnerable, despite having low Endemia at the national level.